Uberlingen, Germany

Norbert Otterbeck

USPTO Granted Patents = 10 

Average Co-Inventor Count = 1.4

ph-index = 6

Forward Citations = 289(Granted Patents)


Company Filing History:


Years Active: 1999-2015

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Norbert Otterbeck: Pioneering Pharmaceutical Solutions

Introduction

Norbert Otterbeck, an inventor based in Uberlingen, Germany, has made significant contributions to the field of pharmaceuticals with a total of 10 patents to his name. His work primarily focuses on innovative formulations aimed at improving the treatment of intestinal tract diseases.

Latest Patents

Among his latest innovations, Otterbeck has developed an orally administrable pharmaceutical pellet formulation for the treatment of the intestinal tract. This formulation features a unique design consisting of a core and an enteric coating. The core includes aminosalicylic acid or a pharmaceutically tolerable salt or derivative thereof, enhancing the efficacy of the treatment.

Career Highlights

Norbert Otterbeck has dedicated his career to advancing pharmaceutical therapies, particularly in the area of gastrointestinal health. His role at Dr. Falk Pharma GmbH has allowed him to translate his innovative ideas into tangible treatment options that benefit patients worldwide.

Collaborations

Throughout his career, Otterbeck has collaborated with talented professionals, including colleagues Peter Gruber and Reimund Kuhn. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical products.

Conclusion

Norbert Otterbeck's inventive spirit and commitment to improving health outcomes through innovative pharmaceuticals highlight the essential role of inventors in the medical field. As he continues to explore new frontiers in treatment formulations, his contributions remain a valuable asset to the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…